热门出版物 - 学术资源搜索

h5 指数:66
h5 中位数:94

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#15 Gerontology & Geriatric Medicine

标题/作者	引用次数	年份
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease MT Heneka, D Golenbock, E Latz, D Morgan, R Brown Alzheimer's Research & Therapy 12, 1-3	492	2020
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody CJ Swanson, Y Zhang, S Dhadda, J Wang, J Kaplow, RYK Lai, L Lannfelt, ... Alzheimer's Research & Therapy 13, 1-14	308	2021
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease O Hansson, S Lehmann, M Otto, H Zetterberg, P Lewczuk Alzheimer's Research & Therapy 11, 1-15	305	2019
The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease NM Vogt, KA Romano, BF Darst, CD Engelman, SC Johnson, ... Alzheimer's Research & Therapy 10, 1-8	259	2018
Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval M Tolar, S Abushakra, JA Hey, A Porsteinsson, M Sabbagh Alzheimer's Research & Therapy 12, 1-10	236	2020
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease P Lewczuk, N Ermann, U Andreasson, C Schultheis, J Podhorna, ... Alzheimer's Research & Therapy 10, 1-10	234	2018
Cognitive impact of COVID-19: looking beyond the short term S Miners, PG Kehoe, S Love Alzheimer's Research & Therapy 12 (1), 1-16	214	2020
Alcohol use and dementia: a systematic scoping review J Rehm, OSM Hasan, SE Black, KD Shield, M Schwarzinger Alzheimer's Research & Therapy 11, 1-11	212	2019
Clinical prevalence of Lewy body dementia JPM Kane, A Surendranathan, A Bentley, SAH Barker, JP Taylor, ... Alzheimer's Research & Therapy 10, 1-8	197	2018
The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease M Colom-Cadena, T Spires-Jones, H Zetterberg, K Blennow, A Caggiano, ... Alzheimer's Research & Therapy 12, 1-12	173	2020
Aducanumab produced a clinically meaningful benefit in association with amyloid lowering J Cummings, P Aisen, C Lemere, A Atri, M Sabbagh, S Salloway Alzheimer's Research & Therapy 13 (1), 98	168	2021
The “rights” of precision drug development for Alzheimer’s disease J Cummings, HH Feldman, P Scheltens Alzheimer's Research & Therapy 11 (1), 1-14	160	2019
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification NR Barthélemy, RJ Bateman, C Hirtz, P Marin, F Becher, C Sato, ... Alzheimer's Research & Therapy 12 (1), 1-11	145	2020
Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis G Klein, P Delmar, N Voyle, S Rehal, C Hofmann, D Abi-Saab, ... Alzheimer's Research & Therapy 11 (1), 1-12	145	2019
Brief cognitive screening instruments for early detection of Alzheimer’s disease: a systematic review EE De Roeck, PP De Deyn, E Dierckx, S Engelborghs Alzheimer's Research & Therapy 11 (1), 1-14	139	2019
Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE) F Jessen, A Spottke, H Boecker, F Brosseron, K Buerger, C Catak, ... Alzheimer's Research & Therapy 10 (1), 1-10	134	2018
A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain JL Del-Aguila, Z Li, U Dube, KA Mihindukulasuriya, JP Budde, ... Alzheimer's Research & Therapy 11 (1), 1-16	128	2019
18 F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes RM Tsai, A Bejanin, O Lesman-Segev, R LaJoie, A Visani, V Bourakova, ... Alzheimer's Research & Therapy 11, 1-18	123	2019
Systemic and central nervous system metabolic alterations in Alzheimer’s disease V van der Velpen, T Teav, H Gallart-Ayala, F Mehl, I Konz, C Clark, ... Alzheimer's Research & Therapy 11, 1-12	122	2019
In vivo quantification of neurofibrillary tangles with [18F] MK-6240 TA Pascoal, M Shin, MS Kang, M Chamoun, D Chartrand, ... Alzheimer's Research & Therapy 10 (1), 1-14	120	2018

1 - 20

计算机程序会自动估算并确定日期和引用次数。